Genmab — Juli 2018
-
God morgen

-
article on daratumumab interference with standard types of blood-compatibility tests - F(ab′)2 Fragments to Overcome Daratumumab Interference in Transfusion Tests - https://www.nejm.org/doi/full/10.1056/NEJMc1804751
-
So Dara now has EMA orphan designation for Treatment of AL amyloidosis http://www.ema.europa.eu/docs/en_GB/document_library/Minutes/2018/06/WC500251173.pdf p18 - http://www.ema.europa.eu/docs/en_GB/document_library/Committee_meeting_report/2018/06/WC500250581.pdf
p7 -
That is certanly good news. Thank you E L.

-
-
Det er en meget lille indikation uden effektive behandlingsmuligheder.
-
Jeg mener, at Novod for et par år siden fortalt en fantastisk historie om virkningen af Daratumumab hos en kvinde med sygdommen.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind